Albumin adjuvant therapy for acute ischemic stroke with large vessel occlusion (AMASS-LVO): rationale, design, and protocol for a phase 1, open-label, clinical trial
Authors
Shuling Liu (ORCID: https://orcid.org/0000-0003-2754-6049)
Chen Cao (ORCID: https://orcid.org/0000-0002-1704-3459)
Leilei Luo (ORCID: https://orcid.org/0000-0003-4843-5225)
National Health Commission of the People's Republic of China
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article
Albumin adjuvant therapy for acute ischemic stroke with large vessel occlusion (AMASS-LVO): rationale, design, and protocol for a phase 1, open-label, clinical trial
Shuling Liu, Chen Cao, Leilei Luo, Jian Chen et al.
Citations
4 citations
Journal
Frontiers in Neurology
Topics
Acute Ischemic Stroke Management
Field-Weighted Citation Impact (FWCI)
1.55
article
Albumin adjuvant therapy for acute ischemic stroke with large vessel occlusion (AMASS-LVO): rationale, design, and protocol for a phase 1, open-label, clinical trial
Shuling Liu, Chen Cao, Leilei Luo, Jian Chen, Sifei Wang, Yongbo Xu, Ming Wei, Sihu Pan, Kangjie Du, Xunming Ji
article en
4 citations
Abstract
No abstract available for this paper.
Publication Tag
Frontiers in NeurologyVol. 15
Institutions
Tianjin Huanhu Hospital (CN), Beijing Xuanwu Traditional Chinese Medicine Hospital (CN), Tianjin Medical University (CN)
Funders
Beijing Postdoctoral Science Foundation, National Health Commission of the People's Republic of China